VisCardia will soon be enrolling almost 300 patients in a clinical trial.

Johnson & Johnson MedTech is presenting new clinical and real-world evidence from the VARIPULSE Platform. The company will ...

This design is intended to meet the growing demand for flexible, high-performance signal sources used in a variety of fields ...

Abstract: The pulse parameter-editable nanosecond pulse power supply (NPPS) based on all-solid-state Marx power topology is one of the critical excitation sources for studying the characteristics of ...

We use cookies to improve your website experience and to analyse our traffic. We also share non-personally identifiable information about your use of our site with our analytics partners. By ...